Association of the Apolipoprotein A-I gene polymorphisms with cardiovascular disease risk factors and atherogenic indices in patients from assam, Northeast India
Authors:
Open Access
- 1 June 2017
- journal article
- research article
- Published by Walter de Gruyter GmbH in Balkan Journal of Medical Genetics
- Vol. 20 (1) , 59-70
Abstract
Cardiovascular disease (CVD) risk factors, and particularly decreased high density lipoprotein cholesterol (HDL-C) dyslipidemia are prevalent in Assam, India. This study was undertaken to investigate whether Apolipoprotein A-I (APOA1) gene polymorphisms (G-75A and C+83T) were associated with i) the risk for decreased HDL-C, and ii) other CVD risk factors, viz. serum lipids, atherogenic indices, obesity, and blood pressure (BP). A total of 649 subjects were screened, from which 200 eligible individuals, classified as case group with decreased HDL-C levels (100 subjects) and control group with normal HDL-C levels (100 subjects) were enrolled and genotyped using polymersase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing. Lipid fractions [HDL-C, total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol (VLDL-C), triglycerides (TG)] and atherogenic indices [Castelli’s Risk Indices-I and -II (CRI-I and -II), non-HDL-C fraction, atherogenic index of plasma (AIP), atherogenic coefficient (AC)] were estimated. The G-75A and C+83T loci were not associated with decreased HDL-C risk. This was confirmed across different genetic models (dominant, recessive, additive and allelic). Association was also absent with BP and obesity. However, the G-75A locus was associated with LDL-C, whereas the C+83T locus was associated with TG and VLDL-C. Furthermore, these sites had effects on atherogenic indices. The rare A allele at the G-75A locus was associated with adverse CRI-I, CRI-II, non-HDL-C and AC values, while the major C allele at the C+83T locus was associated with adverse AIP values. Thus, the pro-atherogenic G-75A polymorphism and the anti-atherogenic C+83T polymorphism represent important genetic loci that modulate CVD risk factors in subjects from Assam.Keywords
This publication has 40 references indexed in Scilit:
- Re-sequencing of the APOAI promoter region and the genetic association of the -75G > A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti populationBMC Medical Genetics, 2013
- The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up studyBMC Cancer, 2013
- Associations of Polymorphisms in the Apolipoprotein APOA1-C3-A5 Gene Cluster with Acute Coronary SyndromeJournal of Biomedicine and Biotechnology, 2012
- Polymorphism in apoA1 Influences High-Density Lipoprotein Cholesterol Levels but Is Not a Major Risk Factor of Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders Extra, 2011
- Association of apoprotein A-1 genetic variants with development of atherosclerosis in the population of St. PetersburgRussian Journal of Genetics: Applied Research, 2011
- Apolipoprotein A1 Gene Polymorphism (G–75A and C+83T) in Patients With Myocardial InfarctionAmerican Journal of Clinical Pathology, 2010
- Association of two apolipoprotein A-I gene MspI polymorphisms with lipid and blood pressure levelsInternational Journal of Cardiology, 2005
- NewMspI polymorphism at +83 bp of the human apolipoprotein al gene: Association with increased circulating high density lipoprotein cholesterol levelsGenetic Epidemiology, 1996
- A study of DNA polymorphisms around the human apolipoprotein Al gene in hyperlipidaemic and normal individualsClinical Genetics, 1985
- Summary estimates of cholesterol used to predict coronary heart disease.Circulation, 1983